Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
基本信息
- 批准号:8729296
- 负责人:
- 金额:$ 29.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAmerican IndiansAppalachian RegionCaringCervicalCervical Cancer ScreeningClinicClinicalClinical SensitivityCollectionCommunitiesCommunity PracticeComplexContinuity of Patient CareCounselingCountryCytologyDNADecision MakingDevelopmentDiseaseDocumentationEffectivenessEvaluationFailureHispanicsHome environmentHuman PapillomavirusIncomeInterventionIntervention TrialInterviewLifeLinkMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsMexicoMississippiNew MexicoOutcomeOutcome MeasurePatient CarePatientsPerformancePhasePopulationPovertyPrevention programPrimary Health CareProcessProviderResourcesSample SizeSamplingSelf AssessmentSpecimenTest ResultTestingTranslational ResearchUnderserved PopulationWomanWorkagedbasecancer carecervical cancer preventioncervicovaginaldesignexperienceinnovationmedically underservednovel strategiespatient populationprimary care settingprogramsscreeningtranslational studywillingness
项目摘要
Failures to screen women for cervical cancer are well documented. The current U.S. screening program
fails to reach small pockets of populations living mainly in low-resource, medically underserved regions as
part of a complex of diseases linked to poverty and/or racial disparities. These populations have cen/ical
cancer rates that are similar to middle-income countries and contribute approximately 60% of the cervical
cancer cases that occur annually in the U.S. it is reasonable to suggest that the current cervical cancer
prevention program has reached its limits and innovative strategies are needed to overcome these
barriers and further reduce the burden in underserved populations. HPV DNA testing offers a promising
strategy to enhance cervical screening coverage and address both patient and primary care provider
challenges along the care process. HPV DNA testing is highly sensitive (90-95%) for identifying women
with cervical precancer and cancer when using a clinician-collected specimen, and 20-50% more sensitive
than routine cytology programs. Thus, self-collection combined with HPV DNA testing can potentially be
used to extend access to women who are not reached by current Pap-based programs. However, there
are only limited, small studies of self-collection in the U.S. and more work is needed to determine whether
self-collection is acceptable to diverse patient populations as well as potential barriers toward integration
of this approach into primary care settings. This mixed method study is designed to:
1. fully describe the current cervical cancer screening and treatment care continuum, and to assess the
translational potential of a promising new approach - self-collection - by conducting a three-phase
sequential mixed-method translational study (Phase la):
2. involve American Indian and Hispanic women in the co-development of a culturally-appropriate
approach to self-collection (Phase lb):
3. integrate practice assessment and patient findings (Aims 1 and 2) in an intervention to assess the
feasibility and comparability of self-collection methods for HPV testing and routine cervical cytology with
HPV co-testing in four purposefully selected primary care clinical settings: (Phase 2)
未能对女性进行宫颈癌筛查的情况已有充分记录。美国目前的筛查计划
未能惠及主要生活在资源匮乏、医疗服务不足地区的一小部分人口,因为
与贫困和/或种族差异有关的一系列疾病的一部分。这些人群有疾病
癌症发病率与中等收入国家相似,约占宫颈癌的 60%
根据美国每年发生的癌症病例,有理由认为目前的宫颈癌
预防计划已达到其极限,需要创新战略来克服这些问题
障碍并进一步减轻服务不足人群的负担。 HPV DNA 检测提供了一个有前途的方法
提高宫颈筛查覆盖率并解决患者和初级保健提供者问题的策略
护理过程中的挑战。 HPV DNA 检测对于识别女性具有高度敏感性 (90-95%)
使用临床医生采集的样本时,可发现宫颈癌前病变和癌症,敏感性提高 20-50%
比常规细胞学程序。因此,自我收集与 HPV DNA 检测相结合可能会
用于扩大目前基于宫颈抹片计划未覆盖的女性的使用范围。然而,有
仅对美国的自我收集进行了有限的小型研究,需要做更多的工作来确定是否
自助收集对于不同的患者群体来说是可以接受的,但也存在融合的潜在障碍
将这种方法引入初级保健机构。这项混合方法研究旨在:
1. 全面描述当前宫颈癌筛查和治疗护理的连续性,并评估
通过进行三个阶段,自我收集这一有前途的新方法的转化潜力
序贯混合方法转化研究(la 期):
2. 让美洲印第安人和西班牙裔妇女参与共同开发适合文化的项目
自行收集的方法(第 lb 阶段):
3. 将实践评估和患者发现(目标 1 和 2)整合到干预措施中,以评估
HPV检测和常规宫颈细胞学检查的自我收集方法的可行性和可比性
在四个特意选择的初级保健临床环境中进行 HPV 联合检测:(第 2 阶段)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Louis Sussman其他文献
Andrew Louis Sussman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Louis Sussman', 18)}}的其他基金
Women in Survivorship Healthcare (WISH): Implementation of a Nurse Navigation Model for Medically Underserved Breast and Gynecologic Cancer Survivors using Project ECHO
女性幸存者医疗保健 (WISH):使用 ECHO 项目为医疗服务不足的乳腺癌和妇科癌症幸存者实施护士导航模型
- 批准号:
10021610 - 财政年份:2019
- 资助金额:
$ 29.77万 - 项目类别:
Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
- 批准号:
8555412 - 财政年份:2011
- 资助金额:
$ 29.77万 - 项目类别:
Participatory Research to Understand the Translation of HPV Vaccine Policy
了解 HPV 疫苗政策转化的参与式研究
- 批准号:
7497826 - 财政年份:2008
- 资助金额:
$ 29.77万 - 项目类别:
Participatory Research to Understand the Translation of HPV Vaccine Policy
了解 HPV 疫苗政策转化的参与式研究
- 批准号:
7690200 - 财政年份:2008
- 资助金额:
$ 29.77万 - 项目类别:
Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
- 批准号:
8566819 - 财政年份:
- 资助金额:
$ 29.77万 - 项目类别:
相似海外基金
Diseases of Despair in Young Adulthood: Risk, Resilience, and Prevention
青年期的绝望疾病:风险、恢复力和预防
- 批准号:
9917845 - 财政年份:2018
- 资助金额:
$ 29.77万 - 项目类别:
Diseases of Despair in Young Adulthood: Risk, Resilience, and Prevention
青年期的绝望疾病:风险、恢复力和预防
- 批准号:
9903905 - 财政年份:2018
- 资助金额:
$ 29.77万 - 项目类别:
Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
- 批准号:
8555412 - 财政年份:2011
- 资助金额:
$ 29.77万 - 项目类别: